Remove production unit-operations
article thumbnail

STAT+: As supply crunch starts to ease, Novo Nordisk to offer more doses of obesity drug Wegovy to U.S. patients

STAT

LONDON — Novo Nordisk said Wednesday that it had started to increase the availability of its blockbuster obesity drug Wegovy for new patients in the United States, after massive demand and a supply crunch had led it to limit such doses last May. The company also projected double-digit growth in sales and operating profit for 2024.

Diabetes 290
article thumbnail

Polar Leasing Validation Reports

Pharmaceutical Commerce

Polar Leasing temperature controlled cold rooms offer accurate temperature control for temperature sensitive product storage. They also provide the flexibility to move the refrigerated unit to various parts of your facility as areas of need change.

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AI in packaging and labelling processes

Express Pharma

Packaging and labelling, being an integral part of the products, are also transforming by adopting such contemporary technologies to remain at par with the industry standards across the globe. It can also help to enhance productivity, minimise process cycle time, improve accuracy and maintain consistency.

article thumbnail

Asahi Kasei Bioprocess and Axolabs partner to accelerate oligonucleotide therapeutics development

Express Pharma

Oligonucleotide therapies offer a targeted approach to modulating gene expression, splicing, and protein production. Operations at the newly built facility are planned to commence in late 2024. By selectively manipulating specific molecular processes, these therapies hold the potential to treat a wide range of diseases (e.g.,

89
article thumbnail

STAT+: Pharmalittle: Roche data on immunotherapy accidentally released; Novo Nordisk hires Thermo Fisher to manufacture Wegovy

STAT

The Danish drugmaker is scrambling to boost output of the drug to meet soaring demand in the United States and after production problems at the factory in Belgium operated by its first contract manufacturer, Catalent. The company had previously said it had enlisted a second contract manufacturer, but had not identified it.

article thumbnail

Natco Pharma Limited -Walk-In Interview for Multiple Positions On 28th Jan’ 2023

Pharma Pathway

Our focus is primarily on niche therapeutic areas and complex products. We market and distribute our products in over 40 countries. We sell our FDF products in the United States, India, Europe and the rest of the world (“RoW”). We also operate in certain key geographies through our subsidiaries.

Dosage 86
article thumbnail

Hetero Labs Limited-Walk-In Interviews for QA/ Production On 17th Sept’ 2022

Pharma Pathway

Hetero Labs Limited-Walk-In Interviews for QA/ Production On 17th Sept’ 2022. The company is recognized for its strengths in Research and Development, manufacturing and commercialization of a wide range of products. Walk-In Interviews for Experienced Candidates in QA/Production Dept. Department: QA/ Production.